Life Sciences Tools and Services
Company Overview of Paragon Bioservices, Inc.
Paragon Bioservices, Inc. operates as a contract research and manufacturing organization that focuses on the development and manufacturing of biopharmaceuticals. It engages in the production and purification of therapeutic proteins, monoclonal antibodies, viral vectors, and vaccines-VLPs, as well as production of master and working cell banks. The company provides research services, such as protein expression, antibody services, viruses and VLPs, bacteriophage, vaccines, stem cell services, electron microscopy, and quality systems; good manufacturing practices (GMP) manufacturing, including process development, cell banking services, GMP manufacturing of biopharmaceuticals, GMP virus facilit...
801 West Baltimore Street
Baltimore, MD 21201
Founded in 1990
Key Executives for Paragon Bioservices, Inc.
Chief Executive Officer, President and Director
Senior Vice President of GMP Operations
Vice President of Business Development and Principal Scientist
Senior Vice President of GMP Manufacturing
Compensation as of Fiscal Year 2017.
Paragon Bioservices, Inc. Key Developments
Paragon Bioservices, Inc. Appoints Deborah Wild as Vice President, Quality and Regulatory Affairs
Jul 20 17
Paragon Bioservices, Inc. announced the appointment of Deborah Wild to the position of Vice President, Quality and Regulatory Affairs, where she will focus on accelerating quality agenda. Ms. Wild is an accomplished Quality Executive/Leader with 30 years' experience. Most recently she ran a thriving consulting practice, for over 14 years, leading Quality Assurance focused initiatives for high profile clients such as Genentech, TEVA, Polynoma, Cytovance, CMC Biologics, etc.
NIAID Awards Paragon Bioservices Multiple Award IDIQ Contract Valued Up to $159 Million for Preclinical Drug Development Services
Jan 17 17
Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for a variety of National Institute of Allergy and Infectious Diseases (NIAID) medical product development activities. The IDIQ mechanism will allow Paragon to compete within a contractor pool for task order awards up to $159 million. Paragon Bioservicesis one of four awardees to receive the IDIQ valued up to $159 million, with a period of performance of up to 10 years. The award covers the development and introduction of new therapeutic products against a range of critical global infectious diseases. Under the contract, the company will develop manufacturing processes and analytical test methods and perform product characterization.
Paragon Bioservices, Inc. Appoints John Conner as SVP GMP Manufacturing
Nov 22 16
Paragon Bioservices, Inc. announced the appointment of John Conner to the position of Senior Vice President of GMP Manufacturing. He has over 30 years. He was most recently the Senior Vice President of Operations at the start-up CDMO Cytovance Biologics.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 8, 2017